Issue 41, 2019, Issue in Progress

Photocatalytic efficacy of supported tetrazine on MgZnO nanoparticles for the heterogeneous photodegradation of methylene blue and ciprofloxacin

Abstract

MgZnO@SiO2-tetrazine nanoparticles were synthesized and their photocatalytic efficiency was demonstrated in the decomposition of ciprofloxacin and methylene blue (MB). This new heterogeneous nanocatalyst was characterized by FT-IR, XRD, UV-vis, DRS, FE-SEM, ICP, and CHN. Distinctive variables including photocatalyst dose, pH, and degradation time were investigated. Up to 95% photodegradation was gained under the optimum conditions (20 mg photocatalyst, 3.5 ppm MB, pH 9) by using MgZnO@SiO2-tetrazine nanoparticles after 20 min. An elementary kinetic study was carried out, and a pseudo-first-order kinetic with a reasonably high rate-constant (0.068 min−1) was derived for the MB decay. Photoluminescence (PL) studies confirmed that the photocatalytic activity of MgZnO@SiO2-tetrazine was almost consistent with the Taugh plots. Thus, it can be envisaged that the photocatalytic activity is closely related to the optical absorption. Furthermore, a photoreduction mechanism was suggested for the degradation process. Addition of scavengers and some mechanistic studies also revealed that O2˙ is the original radical accounting for the degradation of MB, considering this latter compound as a model type pollutant. Finally, efficacy of the present photocatalytic process was assessed in the degradation of ciprofloxacin as a model drug under the optimum reaction conditions.

Graphical abstract: Photocatalytic efficacy of supported tetrazine on MgZnO nanoparticles for the heterogeneous photodegradation of methylene blue and ciprofloxacin

Article information

Article type
Paper
Submitted
23 Jun 2019
Accepted
22 Jul 2019
First published
31 Jul 2019
This article is Open Access
Creative Commons BY license

RSC Adv., 2019,9, 23818-23831

Photocatalytic efficacy of supported tetrazine on MgZnO nanoparticles for the heterogeneous photodegradation of methylene blue and ciprofloxacin

E. Parvizi, R. Tayebee, E. Koushki, M. F. Abdizadeh, B. Maleki, P. Audebert and L. Galmiche, RSC Adv., 2019, 9, 23818 DOI: 10.1039/C9RA04702F

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements